Skystar Bio-Pharm of Xi’an Raises $5 Million

Skystar Bio-Pharmaceutical, a China veterinary medicine company headquartered in Xi’an, raised $5 million through a private placement. The company said it would use the funds for acquisitions, in-licensing of vaccine and aquaculture products, and R&D, along with general corporate purposes. Before the transaction, Skystar had just under $7 million in cash. More details.... Stock Symbol: (NSDQ: SKBI) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.